HomeCompareNOPE vs NOBL

NOPE vs NOBL: Dividend Comparison 2026

NOPE yields 23.89% · NOBL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOPE wins by $64.4K in total portfolio value
10 years
NOPE
NOPE
● Live price
23.89%
Share price
$8.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$92.4K
Annual income
$10,010.35
Full NOPE calculator →
NOBL
NOBL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NOBL calculator →

Portfolio growth — NOPE vs NOBL

📍 NOPE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNOPENOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NOPE + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NOPE pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NOPE
Annual income on $10K today (after 15% tax)
$2,030.70/yr
After 10yr DRIP, annual income (after tax)
$8,508.80/yr
NOBL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, NOPE beats the other by $7,744.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NOPE + NOBL for your $10,000?

NOPE: 50%NOBL: 50%
100% NOBL50/50100% NOPE
Portfolio after 10yr
$60.2K
Annual income
$5,454.77/yr
Blended yield
9.05%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NOPE buys
0
NOBL buys
0
No recent congressional trades found for NOPE or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNOPENOBL
Forward yield23.89%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR0%5%
Portfolio after 10y$92.4K$28.0K
Annual income after 10y$10,010.35$899.19
Total dividends collected$57.3K$6.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: NOPE vs NOBL ($10,000, DRIP)

YearNOPE PortfolioNOPE Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$13,089$2,389.06$11,120$420.00+$2.0KNOPE
2$16,928$2,922.48$12,357$458.31+$4.6KNOPE
3$21,645$3,532.31$13,721$499.76+$7.9KNOPE
4$27,381$4,221.18$15,227$544.58+$12.2KNOPE
5$34,289$4,990.53$16,885$593.02+$17.4KNOPE
6$42,529$5,840.60$18,713$645.34+$23.8KNOPE
7$52,277$6,770.38$20,724$701.81+$31.6KNOPE
8$63,714$7,777.67$22,938$762.73+$40.8KNOPE
9$77,033$8,859.12$25,372$828.41+$51.7KNOPE
10$92,436$10,010.35$28,047$899.19+$64.4KNOPE

NOPE vs NOBL: Complete Analysis 2026

NOPEStock

The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by purchasing long positions in securities expected to increase in price and/or taking short positions in securities expected to decline in price. The fund may invest in the securities of U.S. and international exchange-listed large-, mid-, and small-capitalization companies. It is non-diversified.

Full NOPE Calculator →

NOBLETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →
📬

Get this NOPE vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NOPE vs SCHDNOPE vs JEPINOPE vs ONOPE vs KONOPE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.